Enzo Biochem Inc
NYSE:ENZ
Enzo Biochem Inc
NYSE:ENZ
Price:
1.04 USD
Market Closed
Updated:
May 4, 2024
Enzo Biochem Inc
Cash from Investing Activities
|
Enzo Biochem Inc
Cash from Investing Activities Peer Comparison
Comparables:
DVA
DGX
CVS
CI
LH
Competitive Cash from Investing Activities Analysis
Latest Figures & CAGR of Competitors
Latest Figures & CAGR of Competitors
| Company | Cash from Investing Activities | CAGR 3Y | CAGR 5Y | CAGR 10Y | |
|---|---|---|---|---|---|
|
|
Enzo Biochem Inc
NYSE:ENZ
|
Cash from Investing Activities
$100.2m
|
CAGR 3-Years
N/A
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
|
DaVita Inc
NYSE:DVA
|
Cash from Investing Activities
-$771.8m
|
CAGR 3-Years
2%
|
CAGR 5-Years
5%
|
CAGR 10-Years
1%
|
|
|
Quest Diagnostics Inc
NYSE:DGX
|
Cash from Investing Activities
-$1.1B
|
CAGR 3-Years
-19%
|
CAGR 5-Years
-10%
|
CAGR 10-Years
-21%
|
|
|
CVS Health Corp
NYSE:CVS
|
Cash from Investing Activities
-$14.5B
|
CAGR 3-Years
-36%
|
CAGR 5-Years
20%
|
CAGR 10-Years
-14%
|
|
|
Cigna Corp
NYSE:CI
|
Cash from Investing Activities
-$5.2B
|
CAGR 3-Years
N/A
|
CAGR 5-Years
28%
|
CAGR 10-Years
N/A
|
|
|
Laboratory Corporation of America Holdings
NYSE:LH
|
Cash from Investing Activities
-$1.5B
|
CAGR 3-Years
-30%
|
CAGR 5-Years
N/A
|
CAGR 10-Years
-14%
|
See Also
What is Enzo Biochem Inc's Cash from Investing Activities?
Cash from Investing Activities
100.2m
USD
100.2m
USD
Based on the financial report for Jan 31, 2024, Enzo Biochem Inc's Cash from Investing Activities amounts to 100.2m USD.
What is Enzo Biochem Inc's Cash from Investing Activities growth rate?
Cash from Investing Activities CAGR 1Y
285%
285%
Over the last year, the Cash from Investing Activities growth was 285%.
You don't have any saved screeners yet
